Enhanced tumor necrosis factor alpha in coronavirus but not in paracetamol‐induced acute hepatic necrosis in mice
Open Access
- 1 August 1992
- journal article
- Published by Wiley in Liver International
- Vol. 12 (4) , 205-208
- https://doi.org/10.1111/j.1600-0676.1992.tb01048.x
Abstract
Previous reports have demonstrated that tumor necrosis factor alpha (TNF‐α) plays an important role in the pathogenesis of fulminant hepatic necrosis. The purpose of this experimental study was to measure TNF‐α blood activity in paracetamol‐induced liver necrosis and in coronavirus (MHV3)‐induced fulminant hepatitis in mice. No elevation of TNF‐α activity was found in hepatic failure complicating paracetamol poisoning. In contrast, TNF‐α activity significantly increased in response to MHV3, reaching 16.3 ± 5.5 U/ml from 24 h post infection (P>0.01). This augmentation was observed even though the virus was not detectable in the liver. Serum alanine aminotransferase levels were low and no histological lesion was observed. In conclusion, our study further supports the implication of TNF‐α in virus‐induced hepatitis failure and confirms that paracetamol poisoning does not cause increased TNF‐α activity in the circulation.Keywords
This publication has 18 references indexed in Scilit:
- Tumour necrosis factor production in fulminant hepatic failure: relation to aetiology and superimposed microbial infectionClinical and Experimental Immunology, 1990
- Mechanism of Protective Effect of Prostaglandin E in Murine Hepatitis Virus Strain 3 Infection: Effects on Macrophage Production of Tumour Necrosis Factor, Procoagulant Activity and Leukotriene B4Published by Springer Nature ,1990
- Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in miceBiochemical Pharmacology, 1989
- Tumor necrosis factor α stimulates leukotriene production in vivoEuropean Journal of Immunology, 1988
- Leukotrienes as Mediators in Diseases of the LiverSeminars in Liver Disease, 1988
- ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILUREThe Lancet, 1988
- A human inhibitor of tumor necrosis factor alpha.The Journal of Experimental Medicine, 1988
- Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice.The Journal of Experimental Medicine, 1987
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Comparison of in vitro cell cytotoxic assays for tumor necrosis factorJournal of Immunological Methods, 1984